Analysed ORION OYJ-UNSPON ADR (ORINY:OTCMKTS) News Sources
Orion Pharma announces first patient dosed in Phase 1/2 clinical trial of ODM-216, the company’s first biologic candidate to reach clinical testing
05-10-2026
yahoo.com
Orion Pharma announces agreement with Qilu Pharma Europe for pembrolizumab biosimilar for European market
06-10-2026
yahoo.com
Orion publishes Interim Report for January–September 2026 and holds a webcast on 28 October 2026
14-10-2026
yahoo.com
Darolutamide plus ADT and radiation therapy reduces risk of metastasis or death by 58% in prostate cancer patients at high risk of recurrence
24-10-2026
yahoo.com
What is the current price of ORION OYJ-UNSPON ADR (ORINY:OTCMKTS)?
The current price of ORION OYJ-UNSPON ADR (ORINY:OTCMKTS) is $55.85.
ORION OYJ-UNSPON ADR (ORINY:OTCMKTS) absolute price change since previous trading day?
The absolute price change of ORION OYJ-UNSPON ADR (ORINY:OTCMKTS) since the previous trading day is $1.73.
ORION OYJ-UNSPON ADR (ORINY:OTCMKTS) percentage price change since previous trading day?
The percentage price change of ORION OYJ-UNSPON ADR (ORINY:OTCMKTS) since the previous trading day is 3.1966%.
What is the most recent average sentiment score for ORION OYJ-UNSPON ADR (ORINY:OTCMKTS)?
The most recent average sentiment score for ORION OYJ-UNSPON ADR (ORINY:OTCMKTS) is 59 out of 100.
What is the most recent average sentiment for ORION OYJ-UNSPON ADR (ORINY:OTCMKTS)?
The most recent sentiment for ORION OYJ-UNSPON ADR (ORINY:OTCMKTS) is .
SEC-8K** Filing Available For ORION OYJ-UNSPON ADR (ORINY:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.